当前位置: X-MOL 学术Am. J. Respir. Crit. Care Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Patent Ductus Arteriosus and Lung Magnetic Resonance Imaging Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
American Journal of Respiratory and Critical Care Medicine ( IF 19.3 ) Pub Date : 2024-08-01 , DOI: 10.1164/rccm.202310-1733oc
Kurt R Bjorkman 1 , Kimberley G Miles 1 , Laura E Bellew 2 , Kristin A Schneider 1 , S Melissa Magness 1 , Nara S Higano 3, 4 , Nicholas J Ollberding 5 , X Hoyos Cordon 3 , Russel M Hirsch 1, 4 , Erik Hysinger 2, 3, 4 , Jason C Woods 3, 4 , Paul J Critser 1, 3, 4
Affiliation  

Rationale: Hemodynamically significant patent ductus arteriosus (hsPDA) in premature infants has been associated with bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH). However, these associations remain incompletely understood. Objectives: To assess the associations between hsPDA duration and clinical outcomes, PH, and phenotypic differences on lung magnetic resonance imaging (MRI). Methods: In this retrospective cohort study, we identified all infants with BPD at <32 weeks' gestation who also underwent research lung MRI at <48 weeks' postmenstrual age (PMA) from 2014 to 2022. Clinical echocardiograms were reviewed for hsPDA and categorized as no hsPDA, hsPDA 1-60 days, and hsPDA >60 days. Outcome variables included BPD severity, PH at 36 weeks' PMA, PH after 36 weeks' PMA in the absence of shunt (PH-pulmonary vascular disease [PVD]), tracheostomy or death, and lung phenotype by MRI via modified Ochiai score, indexed total lung volume, and whole-lung hyperdensity. Logistic regression and ANOVA were used. Measurements and Main Results: In total, 133 infants born at 26.2 ± 1.9 weeks, weighing 776 ± 276 g, were reviewed (47 with no hsPDA, 44 with hsPDA 1-60 days, and 42 with hsPDA >60 d). hsPDA duration > 60 days was associated with BPD severity (P < 0.01), PH at 36 weeks' PMA (adjusted odds ratio [aOR], 9.7 [95% confidence interval (CI), 3.3-28.4]), PH-PVD (aOR, 6.5 [95% CI, 2.3-18.3]), and tracheostomy or death (aOR, 3.0 [95% CI, 1.0-8.8]). Duration of hsPDA > 60 days was associated with higher Ochiai score (P = 0.03) and indexed total lung volume (P = 0.01) but not whole-lung hyperdensity (P = 0.91). Conclusions: In infants with moderate or severe BPD, prolonged exposure to hsPDA is associated with BPD severity, PH-PVD, and increased parenchymal lung disease by MRI.

中文翻译:


中度和重度支气管肺发育不良-肺动脉高压的动脉导管未闭和肺磁共振成像表型。



理由:早产儿血流动力学显着的动脉导管未闭 (hsPDA) 与支气管肺发育不良 (BPD) 和肺动脉高压 (PH) 相关。然而,这些关联仍然不完全被理解。目的:评估 hsPDA 持续时间与临床结果、PH 和肺磁共振成像 (MRI) 表型差异之间的关联。方法:在这项回顾性队列研究中,我们确定了 2014 年至 2022 年所有在 <32 周妊娠时患有 BPD 的婴儿,这些婴儿也在 <48 周经后年龄 (PMA) 接受了研究性肺部 MRI 检查。临床超声心动图检查了 hsPDA,并将其分类为无 hsPDA、hsPDA 1-60 天和 hsPDA >60 天。结果变量包括 BPD 严重程度、36 周 PMA 时的 PH、36 周 PMA 后无分流的 PH(PH-肺血管疾病 [PVD])、气管切开术或死亡,以及通过改良 Ochiai 评分通过 MRI 得出的肺表型,索引肺总容量和全肺高密度。使用逻辑回归和方差分析。测量和主要结果:总共审查了 133 名出生于 26.2 ± 1.9 周、体重 776 ± 276 g 的婴儿(47 名无 hsPDA,44 名 1-60 天患有 hsPDA,42 名患有 hsPDA >60 d)。 hsPDA 持续时间 > 60 天与 BPD 严重程度相关 (P < 0.01)、36 周 PMA 时的 PH(调整后优势比 [aOR], 9.7 [95% 置信区间 (CI), 3.3-28.4])、PH- PVD(aOR,6.5 [95% CI,2.3-18.3])和气管切开术或死亡(aOR,3.0 [95% CI,1.0-8.8])。 hsPDA > 60 天的持续时间与较高的 Ochiai 评分(P = 0.03)和指数总肺体积(P = 0.01)相关,但与全肺高密度无关(P = 0.91)。 结论:在患有中度或重度 BPD 的婴儿中,长时间暴露于 hsPDA 与 BPD 严重程度、PH-PVD 以及 MRI 发现的实质肺疾病增加相关。
更新日期:2024-08-01
down
wechat
bug